Lipocine Inc. filed a Current Report on Form 8-K with the Securities and Exchange Commission on September 16, 2026, announcing its participation in a recent investor conference. The company reported that it presented at the H.C. Wainwright 28th Annual Global Investor Conference, which was held in New York City, New York, from September 14 to September 16, 2026.
The filing indicates that a copy of the presentation materials used during the conference is included as Exhibit 99.1 to the report. Lipocine is incorporated in Delaware and is listed on the NASDAQ Stock Market LLC under the ticker symbol LPCN. The company is headquartered at 675 Arapeen Drive, Suite 202, Salt Lake City, Utah.
